Could Novavax Be a Millionaire-Maker Stock?
If you invested $10,000 in Novavax (NASDAQ: NVAX) last March, that principal would be worth nearly $133,000 just one year later. But over the past month or so, Novavax stock has fallen nearly 45% from all-time highs. This has left many investors wondering: What gives?
As it turns out, coronavirus vaccines are by no means immune from the supply and demand dynamics of the market. While many countries are seeing shortages now, countries like the U.S. have already ordered enough to vaccinate their entire populations -- even if some are lost or wasted during transport. Does Novavax have what it takes to overcome this supply glut?
Image source: Getty Images.
Source Fool.com
